|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0023981,
umls-concept:C0027651,
umls-concept:C0185117,
umls-concept:C0220825,
umls-concept:C0262950,
umls-concept:C0332281,
umls-concept:C0441800,
umls-concept:C0596620,
umls-concept:C0872169,
umls-concept:C1261473,
umls-concept:C2349975,
umls-concept:C2911684
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-6-2
|
|
pubmed:abstractText |
This study was conducted to investigate whether( 18)F-fluorodeoxyglucose (FDG) uptake, quantified by positron emission tomography (PET), correlates with histological variables including tumour grade, cell proliferation, cell cycle control integrity and glucose metabolism in patients with bone and soft tissue sarcomas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1619-7070
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
683-91
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16506050-Adolescent,
pubmed-meshheading:16506050-Adult,
pubmed-meshheading:16506050-Aged,
pubmed-meshheading:16506050-Biological Markers,
pubmed-meshheading:16506050-Bone Neoplasms,
pubmed-meshheading:16506050-Female,
pubmed-meshheading:16506050-Fluorodeoxyglucose F18,
pubmed-meshheading:16506050-Glucose,
pubmed-meshheading:16506050-Glucose Transporter Type 1,
pubmed-meshheading:16506050-Humans,
pubmed-meshheading:16506050-Male,
pubmed-meshheading:16506050-Middle Aged,
pubmed-meshheading:16506050-Positron-Emission Tomography,
pubmed-meshheading:16506050-Prospective Studies,
pubmed-meshheading:16506050-Radiopharmaceuticals,
pubmed-meshheading:16506050-Sarcoma,
pubmed-meshheading:16506050-Statistics as Topic
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.
|
|
pubmed:affiliation |
Division of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, 104-0045, Tokyo, Japan. utateish@ncc.go.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
